Using our Arestat™ technology platform, we are developing next generation therapies for our proprietary pipeline and in partnership with leading pharmaceutical and biotech companies

Our Products

Our treatments for people living with chronic disease are designed to advance patient care and improve clinical outcomes

Our Partners

We work with many of the top 20 leading pharmaceutical companies to improve their products, find solutions or create next generation products

Latest News and Events

  • 21st September 2020

    Arecor to present at EASD 2020 – oral presentation of phase I clinical trial of AT247, a novel Ultra Rapid Acting Insulin

  • 25th June 2020

    Arecor featured in New Scientist’s Business and Industry 2020 Life Sciences campaign – bringing effective and affordable drugs to market more quickly

  • 15th June 2020

    Arecor presents positive results for the first phase I clinical trial of AT247, a novel ultra-rapid acting insulin